Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by High Katherine A, Director. Director active across 1 company, notably INCYTE CORP. In total, 5 disclosures have been published. History available since 26 May 2021. The latest transaction was disclosed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Katherine A. High serves as a Director at Incyte Corp. As a board member, she contributes to overseeing the company's operations and shaping its strategy. Katherine brings valuable expertise in the biopharmaceutical sector, helping Incyte innovate and grow. Her commitment to corporate governance is essential for ensuring transparency and accountability.